Barium enema: does splitting the buscopan dose reduce patient discomfort, whilst maintaining image quality?

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN32878249

Enrollment

200

Registered

2004-09-30

Start date

2003-09-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barium enema Surgery Procedure

Interventions

1. 20 mg of buscopan (hyoscine-butylbromide) at the usual point in examination 2. 20 mg of buscopan (hyoscine-butylbromide) split into two doses of 10 mg each, with one dose being administered at the

Eligibility

Inclusion criteria

Inclusion criteria: 200 patients attending for barium enema examination, 100 of which will be the controls

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Completion of examination	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026